Despite ambitious plans to roll out ‘test and start’ to provide immediate treatment to everyone diagnosed with HIV, Mozambique is struggling to respond to an epidemic now affecting 11.5 per cent of adults.
In Maputo, we provide care for HIV patients who need second- or third-line antiretroviral (ARV) treatment and treatment for co-morbidities like Kaposi’s sarcoma or viral hepatitis.
Comprehensive care is also available for multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant TB. We also treat patients with hepatitis C through a treatment programme that began in 2016.
We also provide obstetric care in rural areas and improve access to health services for communities affected by conflict in Morrumbala and Mossurize districts.